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Abstract
Interleukin-1b (IL-1) is a pro-inflammatory cytokine that has been implicated in the regulation of nonrapid eye movement (nonREM)
sleep. IL-1, IL-1 receptors and the IL-1 receptor antagonist (ra) are present normally in discrete brain regions, including the preoptic
area (POA) of the hypothalamus and the adjoining magnocellular basal forebrain (BF). The POA ⁄BF have been implicated in the
regulation of sleep–wakefulness. We hypothesized that IL-1 promotes nonREM sleep, in part by altering the state-dependent
discharge activity of POA ⁄BF neurons. We recorded the sleep–wake discharge profiles of 83 neurons in the lateral POA ⁄BF and
assessed the effects of IL-1, IL-1ra, and IL-ra + IL-1 delivered through a microdialysis probe on state-dependent neuronal discharge
activity. IL-1 decreased the discharge rate of POA ⁄BF neurons as a group (n = 55) but wake-related and sleep-related neurons
responded differently. IL-1 significantly decreased the discharge rate of wake-related neurons. Of 24 wake-related neurons studied,
19 (79%) neurons exhibited a greater than 20% change in their discharge in the presence of IL-1 during waking. IL-1 suppressed the
discharge activity of 18 of 19 responsive neurons. Of 13 sleep-related neurons studied, IL-1 increased the discharge activity of five
and suppressed the discharge activity of four neurons. IL-1ra increased the discharge activity of four of nine neurons and significantly
attenuated IL-1-induced effects on neuronal activity of POA ⁄BF neurons (n = 19). These results suggest that the sleep-promoting
effects of IL-1 may be mediated, in part, via the suppression of wake-related neurons and the activation of a subpopulation of sleep-
related neurons in the POA ⁄BF.
Introduction
Interleukin-1b (IL-1) is a pro-inflammatory cytokine that plays a key
role in mediating a variety of host responses to infection and
inflammation, including fever and other components of the acute
phase response (Rosenwasser, 1998; Rothwell & Luheshi, 2000;
Konsman et al., 2002). A growing body of evidence suggests that IL-1
is involved in the regulation of nonrapid eye movement (nonREM)
sleep under both pathologic and normal physiologic conditions (Obal
& Krueger, 2003). The systemic or intracerebroventricular (ICV)
administration of exogenous IL-1 promotes nonREM sleep (Krueger
et al., 1984; Opp et al., 1991). By contrast, inhibition of endogenous
IL-1 by the IL-1 receptor antagonist (IL-1ra) or anti IL-1 antibodies
administered centrally suppresses spontaneous nonREM sleep (Opp &
Krueger, 1991; Opp & Krueger, 1994; Takahashi et al., 1996). Anti-
IL-1 antibodies also inhibit the compensatory sleep rebound subse-
quent to sleep deprivation (Opp & Krueger, 1994). IL-1 concentrations
in cerebrospinal fluid peak at the onset of sleep (Lue et al., 1988;
Hohagen et al., 1993). Substances or stimuli that induce IL-1
production increase nonREM sleep, whereas substances that inhibit
IL-1 action suppress nonREM sleep (Opp et al., 1988, 1989). IL-1
type 1 receptor knock-out mice spend less time in nonREM sleep than
do wild-type control mice (Fang et al., 1998). Exposure to infectious
challenges induces nonREM sleep in animals (Toth & Krueger, 1988,
1989). Despite numerous findings supporting a role of IL-1 in sleep
regulation, the brain structures, the neuronal pathways and the
neuronal types that mediate IL-1-induced nonREM sleep are poorly
understood.
The preoptic area (POA) of the hypothalamus plays a key role in
multiple physiologic functions, including the regulation of sleep–
wakefulness (Saper et al., 2001; McGinty & Szymusiak, 2003).
Lesions, or reversible inactivation of POA, produce arousal whereas
stimulation of this area produces sleep (Alam & Mallick, 1990;
McGinty et al., 1994; Lu et al., 2000; McGinty & Szymusiak, 2003).
The POA contains sleep-related neurons, i.e. neurons that are activated
at nonREM sleep onset (Sherin et al., 1996; Szymusiak et al., 1998).
The adjoining magnocellular basal forebrain (BF) is critically involved
in electroencephalogram (EEG) activation and behavioral arousal
(Szymusiak et al., 2000; Jones, 2004; Semba, 2004). The BF contains
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a predominant population of wake-related neurons (Alam et al., 1999;
Detari et al., 1999). The physiologic process of nonREM sleep onset is
hypothesized to involve the activation of sleep-related neurons and
inhibition of wake-related neurons.
Various in vivo as well as in vitro studies suggest that POA ⁄BF is
one of the potential sites that mediates IL-1 induced physiologic
effects (Nakashima et al., 1989; Oka et al., 1995; Xi & Toth, 2000).
We hypothesized that the sleep-promoting effects of IL-1 are mediated
via the suppression of wake-related neurons and ⁄ or the activation of
sleep-related neurons in the POA ⁄BF. In this study we determined the
effects of IL-1 delivered locally through a microdialysis probe on the
extracellular discharge activity of recorded POA ⁄BF neurons during
waking and nonREM sleep. We further determined if the effects of
IL-1 on POA ⁄BF neurons were mediated via IL-1 receptors.
Materials and methods
Experimental subjects and surgical procedures
Experiments were performed on nine Sprague–Dawley male rats,
weighing between 250 and 350 g. These rats were maintained on
12 : 12-h light–dark cycle (lights on at 08.00 h) and with food and
water continuously available. All experiments were conducted in
accordance with the National Research Council Guide for the Care
and Use of Laboratory Animals and were approved by Institutional
Animal Research Committee. Under surgical anesthesia (ketamine +
xylazine, 80 : 10 mg ⁄ kg, i.p.) and aseptic conditions, rats were
stereotaxically prepared for chronic recording of EEG and electromy-
ogram (EMG) signals, POA ⁄BF neuronal activity, and microdialysis
delivery of drugs adjacent to the recording site. The details of the
surgical procedure and experimental protocol have been described
previously (Alam et al., 1999). In brief, EEG and EMG electrodes
were implanted according to standard technique (Alam & Mallick,
1990). A single-barrel mechanical microdrive was implanted such that
its tip rested 3 mm above the dorsal aspect of the POA ⁄BF (A, )0.2 to
)0.5; L, 1.4–1.8; H, 4.5–5.5; Paxinos & Watson, 1998). Five pairs of
microwires, each consisting of two 20-lm insulated stainless steel
wires glued together except for 2.0 mm at the tip, were passed through
the barrel such that their tips projected into POA ⁄BF. A microdialysis
guide cannula was implanted 0.3–0.5 mm lateral to the microdrive and
blocked with a stylet.
Substances
IL-1b (recombinant rat IL-1b expressed in Escherichia coli) and the
IL-1ra (recombinant human IL-1ra expressed in E. coli) were
purchased from R & D Systems, Inc. (Minneapolis, USA).
Lyophilized substances were reconstituted in pyrogen-free artificial
cerebrospinal fluid (aCSF; composition in mm, 145 Na+, 2.7 K+,
1.0 Mg2+, 1.2 Ca2+, 1.5 Cl–, pH, 7.2) containing 0.1% bovine serum
albumin, aliquoted and stored at )20 C. Immediately prior to use,
substances were brought to appropriate concentrations by adding
aCSF. Each aliquot was used only once.
Data acquisition
Experiments were started at least 10 days after surgery. All experi-
ments were conducted on unanesthetized and freely behaving animals
during lights-on period. At least 12 h before the beginning of the
recording sessions, the stylet of the microdialysis guide cannula was
replaced by a microdialysis probe (EICOM, Japan; A-I model;
material, regenerated cellulose; semipermeable membrane length,
1 mm; outer diameter, 0.22 mm; molecular cut-off, 50 kDa). The
length of the probe was set such that the extracellular environment of
the recorded neurons was within the estimated dialysis area of the
semipermeable membrane. The microdialysis probe was fixed and
microwires were advanced adjacent to the side of the exposed
microdialysis membrane to minimize the tissue trauma and to ensure
maximum stability of the unit recording. The time taken by the
solution to travel from the reservoir to the tip of the probe was 15–
16 min.
The microdrive was advanced in 25–30-lm steps until action
potential signals with signal-to-noise ratio ‡ 2.0 were found. Individ-
ual action potentials were sorted from amplified raw signals using
Spike 2 software (Cambridge Electronic Design 1401, London, UK).
EEG, EMG and raw microwire signals were digitized and stored on a
disk for subsequent off-line analyses.
The baseline discharge rate of isolated POA ⁄BF neurons was
recorded through 2–3 stable sleep–wake cycles (30–45 min) with
pyrogen-free aCSF. After baseline recordings, 20–25 lL of aCSF
containing 40–50 ng IL-1 or 20 lL aCSF containing 2 lg IL-1ra was
perfused through a microdialysis membrane adjacent to the recorded
neurons for 10–12 min. The in vitro recovery of the probe for IL-1
(molecular weight, 17 kDa), as determined by radio-immunoassay, was
in the range 4–5%. Therefore, the amount of IL-1 delivered into the
POA ⁄BF was estimated to be 2–2.5 ng, a concentration similar to the
lower dose used in earlier studies (Opp et al., 1991). The in vitro
recovery of IL-ra was not determined. However, given the higher
molecular weight of IL-1ra (25 kDa), its delivery was estimated to be
lower than that of IL-1. The concentration of IL-1ra used in this study
was based on previous findings that a 1000–10 000-fold excess of
IL-ra was required to block the effects of IL-1 (Dripps et al., 1991; Opp
& Krueger, 1991). This study was aimed at investigating the acute
effects of IL-1 or IL-1ra on the state-dependent discharge activity of the
POA ⁄BF neurons without triggering strong behavioral responses.
Therefore, the substances were dialysed locally into POA ⁄BF for a
short duration and doses adjusted to detect responses of neurons
without changing behavioral state. To determine if IL-1-induced
changes on POA ⁄BF neuronal discharge were IL-1 receptor mediated,
a subset of neurons was examined for the effects of IL-1 in the presence
of IL-1ra. In those cases, IL-1 was microdialysed immediately after
IL-1ra. After delivery of substances, the perfusion solution was
switched back to aCSF and the recording continued for another
45–90 min or until the discharge rate returned back to the baseline
levels as wash out or recovery. During the entire recording session, rats
were undisturbed except, if necessary, a stable episode of waking for
2–3 min was achieved by mild auditory stimuli or gentle touch.
At the end of the recording session, under deep anesthesia
(100 mg ⁄ kg, i.p., pentobarbital) rats were perfused transcardially
with 0.1 m phosphate buffer followed by 4% paraformaldehyde and
10% and 30% sucrose in phosphate buffer. Brains were removed and
equilibrated in 30% sucrose and then freeze-sectioned at 40 lm
thickness. The location of the microdialysis probe and the microwire
tracts were histologically identified in Nissl-stained sections. The
anatomical distribution of the recorded neurons and their sleep–wake
discharge profiles were plotted (Fig. 1).
Data analysis
Sleep–wake states were identified on the basis of EEG and EMG
patterns using standard criteria (Alam & Mallick, 1990). The baseline
mean discharge rate was calculated from 40- to 300-s blocks of
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stable waking and nonREM sleep during 3–5 spontaneous waking
and nonREM sleep episodes. The discharge rates of neurons during
waking and nonREM sleep in the presence of drugs were determined
by comparing discharge rates during all episodes of waking and
nonREM sleep occurring during the first 20–40 min of drug delivery.
In an earlier study we found that adenosinergic agents produced their
effects within 1–5 min after their arrival into the extracellular space
(Alam et al., 1999). Therefore, effects of IL-1 and ⁄ or IL-1ra were
determined after 5 min of their expected arrival into the extracellular
environment of the recorded neurons. The effects of drugs usually
lasted from 20 to 45 min. In some cases, effects of IL-1 lasted for
more than 60 min. Because drugs were perfused for a short duration,
and REM sleep was usually not observed during drug treatments,
only waking and nonREM sleep-related discharge rates were
analysed.
The sleep–wake discharge profiles of neurons were determined by
criteria adopted previously (Alam et al., 1995; Szymusiak et al.,
1998). Neurons were defined as wake-related if the ratio of their
discharge rates during nonREM sleep and waking (nonREM ⁄wake)
was £ 0.75. Neurons were classified as sleep-related if the non-
REM ⁄wake ratio was ‡ 1.25. Neurons having a nonREM ⁄wake ratio
of > 0.75 and < 1.25 were considered as state-indifferent neurons.
Neurons were considered responsive to drugs if they exhibited a
change in discharge rate that was greater than 20% of the baseline
discharge rate. Neurons discharging less than one spike per second
were not considered for analysis.
The Wilcoxon matched-pairs signed rank test was used to determine
the statistical significance of the IL-1, IL-ra or IL-1ra + IL-1
treatments on the neuronal discharge activity during waking and
nonREM sleep. The Mann–Whitney rank sum test was used to
determine the statistical significance of the difference between IL-1
treatment alone and IL-ra + IL-1 treatments conducted on two
different groups of neurons.
Results
During aCSF perfusion neuronal recordings exhibited stable signal-to-
noise ratio and sleep–wake-related discharge patterns typical of
POA ⁄BF neurons (Szymusiak et al., 1998; Alam et al., 1999; Detari
et al., 1999). The microdialytic perfusion of IL-1, IL-1ra, or IL-1ra
followed by IL-1 consistently affected POA ⁄BF neuronal discharge.
Computer-generated templates, based upon spike shape parameters
used for spike sorting, eliminated possible artifactual spikes and
documented the activity of the same neuron across baseline, drug
delivery and washout conditions (see Figs 2 and 3).
Locations of the recorded neurons
A photomicrograph of representative microwire tracks adjacent to a
microdialysis probe and the anatomical distribution of all recorded
neurons coded with their sleep–wake discharge profiles are shown in
Fig. 1. The majority of recorded neurons were localized in the lateral
POA, including dorsolateral and ventrolateral POA. Additional
recording sites included adjoining caudal portions of the horizontal
limb of the diagonal band of Broca, the substantia innominata and
medial aspects of the magnocellular preoptic nucleus in the BF.
Effects of IL-1 on POA ⁄BF neurons
The effect of IL-1 was studied on 55 POA ⁄BF neurons. IL-1
decreased the mean (± SEM) discharge rate of POA ⁄BF neurons as a
group, irrespective of their sleep–wake discharge profiles, during
waking (5.39 ± 0.67 vs. 3.98 ± 0.73, P < 0.001) and nonREM sleep
(4.85 ± 0.79 vs. 4.1 ± 0.80, P < 0.01). However, discharge profiles of
wake- and sleep-related neurons were differentially affected by IL-1.
Effects of IL-1 on wake-related neurons
The effects of IL-1 on the discharge rate of an individual wake-related
neuron across the sleep–wake cycle and on the mean discharge rate of
wake-related neurons as a group (n ¼ 24) during waking and
nonREM sleep are shown in Figs 2 and 4, respectively. The mean
discharge rate of these neurons during baseline waking was 65%
higher than their mean discharge rate during baseline nonREM sleep
(mean nonREM ⁄wake ratio, 0.35 ± 0.04). The discharge rate of wake-




Fig. 1. Anatomical localization and discharge profiles of the recorded
neurons. (A). Photomicrograph of a histological section through POA ⁄ BF
showing locations of microwire tracks (arrows) and the track of the
microdialysis probe. (B and C) Line drawings of the two representative brain
sections at two rostrocaudal planes showing the distribution of the recorded
neurons. The neuronal recordings were made unilaterally. However, wake-
related neurons and sleep-related neurons have been shown on the right-hand
side and state-indifferent neurons have been shown on the left-hand side of the
drawings for better visualization. Filled circles, wake-related neurons; open
circles, state-indifferent neurons; *, sleep-related neurons; ac, anterior
commissure; ox, optic chiasm; 3V, third ventricle.
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both waking ()47 ± 8%, range )96 to 134%, P ¼ 0.001) and
nonREM sleep ()28 ± 13%, range )99 to 163%, P ¼ 0.031;
Fig. 4). The IL-1-induced suppression in the discharge during waking
was significantly higher than that induced during nonREM sleep
()47 ± 8% vs. )28 ± 11, P ¼ 0.0024).
Individually, 19 of 24 (79%) wake-related neurons exhibited a
greater than 20% change in response to IL-1 during waking. Of 19
responsive neurons, 18 exhibited decreased discharge in the presence
of IL-1 during waking. During nonREM sleep, however, only nine of
these 18 neurons exhibited decreased discharge of greater than 20% in
response to IL-1. One neuron exhibited increased discharge during
both waking and nonREM sleep. One neuron, which was not
responsive to IL-1 during waking, exhibited increased discharge
during nonREM sleep.
Effects of IL-1 on sleep-related neurons
The effects of IL-1 on the discharge rate of an individual sleep-related
neuron and on the mean discharge rate of sleep-related neurons as a
group (n ¼ 13) during waking and nonREM sleep are shown in Figs 3
and 4, respectively. These neurons as a group exhibited 163% higher
discharge during baseline nonREM sleep as compared with baseline
waking (mean nonREM ⁄wake ratio, 2.63 ± 0.54).
Nine of 13 sleep-related neurons (69%) responded to IL-1 perfusion
during waking. Of responsive neurons, five exhibited increased
discharge (199 ± 102%) and four exhibited decreased discharge
()57 ± 10%) in the presence of IL-1 during waking. During nonREM
sleep, these neurons exhibited similar response profiles, except for one
neuron that exhibited increased discharge during waking which
showed a decreased discharge. IL-1 did not alter the discharge rate of
sleep-related neurons as a group during waking (76 ± 51%, range 602
to )81%, P ¼ 0.893) or during nonREM sleep (24 ± 32%, range 250
to )73%, P ¼ 0.789; Fig. 4).
Effects of IL-1 on state-indifferent neurons
Eighteen of the neurons recorded in the POA ⁄BF were state-
indifferent. These neurons had a mean nonREM ⁄wake discharge
ratio of 0.92 ± 0.04. IL-1 decreased the activity of state-indifferent
neurons without inducing any differential effects during waking
Fig. 2. Effects of IL-1 on an individual wake-related neuron. (A) A 52-min continuous recording showing the discharge rate of an individual wake-related neuron
during baseline, in the presence of IL-1 and during washout. Filled and blank arrows indicate arrival of IL-1 at the microdialysis probe and the beginning of IL-1
washout, respectively. IL-1 was perfused for 12 min. Panels B–D are expanded tracings of the marked areas in A, showing wake- and sleep-related neuronal dis-
charge during baseline (B), during IL-1 perfusion (C) and after washout (D). The action potentials on the side panels represent the average waveforms of all the
action potentials recorded during the representative sections in each condition. The numbers represent discharge rates (spikes per second) during the marked sections
of the recording period. EEG, electroencephalogram; EMG, electromyogram.
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()33 ± 7%, range )90 to 47%) or nonREM sleep ()29 ± 10%, range
)96 to 66%, Fig. 4). Of 18 state-indifferent neurons examined, 12
(67%) were responsive to IL-1 during waking, including eleven that
exhibited decreased and one that exhibited increased discharge.
During nonREM sleep, all neurons remained responsive except for
two that exhibited increased discharge.
Effects of IL-1ra on POA ⁄BF neurons
The effect of IL-1ra was examined on the discharge activity of nine
neurons, four wake-related and five state-indifferent (Figs 5 and 6).
Five of nine neurons (56%) responded to IL-1ra perfusion during
waking, including four that exhibited increased (two wake-related and
two state-indifferent) and one (wake-related) that exhibited decreased
discharge. During nonREM sleep, one neuron that was not responsive
during waking exhibited increased discharge. IL-1ra slightly increased
the discharge rate of POA ⁄BF neurons as a group, which was not
significant during both waking (15 ± 11%, range )27 to 86%,
P ¼ 0.865) and nonREM sleep (42 ± 20%, range )13 to 126%,
P ¼ 0.612).
Effects of IL-1 in the presence of IL-1ra on POA ⁄BF neurons
The effect of IL-1ra + IL-1 was examined on the discharge activity of
19 neurons, 12 wake-related and seven state-indifferent. Seven of
these 19 neurons (37%; five wake-related and two state-indifferent)
responded by exhibiting suppressed discharge in response to
IL-1ra + IL-1 during waking.
The effects of IL-1ra + IL-1 on the discharge of an individual wake-
related neuron across the sleep–wake cycle and on the mean discharge
rate of wake-related neurons as a group during waking and nonREM
sleep are shown in Figs 7 and 8, respectively. Only five of 12 wake-
related neurons (42%) responded to IL-1ra + IL-1, whereas the same
dose of IL-1 in the absence of IL-ra suppressed the activity of 75% of
wake-related neurons (see Fig. 4A). Wake-related neurons as a group
exhibited suppressed discharge in the presence of IL-1ra + IL-1
Fig. 3. Effects of IL-1 on an individual sleep-related neuron. (A) A 174-min continuous recording showing the discharge rate of an individual sleep-related neuron
during baseline, in the presence of IL-1 and after washout. Panels B–E are 10-min expanded tracings of the marked areas in A. IL-1 induced increased discharge during
both waking and nonREM sleep in this neuron (onset of effect and the maximum effects are shown in C and D, respectively). The effect of IL-1 persisted after washout
but eventually the discharge rate returned to baseline levels (E). The action potentials on the side panels are the actual spikes captured during 20 s of the representative
sections in each condition. An increase in the number of spikes without any change in spikes can be seen. Other details are as described in the legend to Fig. 2.
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during waking ()19 ± 4%, range )45 to 2%). However, this effect
was significantly weaker than that produced by IL-1 alone (Fig. 8).
IL-ra + IL-1 produced no significant changes in the mean discharge of
POA ⁄BF neurons as a group during waking ()14 ± 4%, range )45 to
18%, P ¼ 0.091) and nonREM sleep (3 ± 7%, range )30 to 78%,
P ¼ 0.623).
Discussion
The present study demonstrates that IL-1 microdialysed locally into
POA ⁄BF suppresses the activity of the majority (75%) of recorded
wake-related neurons in unanesthetized freely behaving animals.
Although the effects of IL-1 on sleep-related neurons in this brain
region are more variable, 39% of all recorded sleep-related neurons
exhibited increased discharge rates in the presence of this cytokine.
The IL-1-induced suppression of POA ⁄BF wake-related neurons was
attenuated by specific IL-1 receptor blockade. Collectively, these
results suggest that IL-1 may promote nonREM sleep by inhibiting
wake-related neurons and activating at least a subpopulation of sleep-
related neurons in the POA ⁄BF. That the effects of IL-1 on the
discharge activity of POA ⁄BF neurons are specific is supported by the
following evidence: (i) the activity of the same neuron was recorded
across baseline, drug delivery and washout conditions as ensured by
digital spike sorting; (ii) for each individual neuron the effects of IL-1
were consistent, reversible and time-linked to the duration of
administration; and (iii) the effect of IL-1 was partially blocked by
IL-ra, although IL-1ra alone at the single given dose had little effect on
the spontaneous discharge rate.
Multiple lines of evidence support a hypothesis that endogenous
IL-1 is involved in sleep regulation (Obal et al., 1990; Opp & Krueger,
1991, 1994; Obal & Krueger, 2003). This is the first study, to our
knowledge, that has examined the effects of locally delivered IL-1 on
the discharge activity of behaviorally identified POA ⁄BF neurons
during spontaneous waking and sleep. It is well documented that
POA ⁄BF neurons play critical roles in the regulation of sleep and
behavioral arousal (Alam et al., 1995; Szymusiak et al., 1998, 2000;
Detari et al., 1999; McGinty & Szymusiak, 2003; Jones, 2004; Semba,
2004). We recorded neurons in the lateral preoptic area, with
additional recording sites in the adjacent horizontal limb of the
diagonal bands of Broca and the medial aspects of the magnocellular
preoptic nucleus and substantia innominata. These latter areas contain
cholinergic neurons that are critically involved in behavioral arousal
and neocortical activation (Szymusiak et al., 2000; Jones, 2004;
Semba, 2004). We can hypothesize that some of the wake-related
neurons that were inhibited by IL-1 in the present study may have
been cholinergic. However, the regions from which we recorded also
contain noncholinergic wake-related neurons, and the extent to which
IL-1 targets cholinergic vs. noncholinergic arousal systems remains to
be determined.
IL-1 administered ICV into rats increases nonREM sleep across an
effective dose range of about 2.5–10 ng (Opp et al., 1991; Gemma
et al., 1997; Imeri et al., 1999). Concentrations of IL-1 greater than
10 ng (e.g. 25 ng) when injected ICV disrupt nonREM sleep and
promote arousal (Opp et al., 1991; Gemma et al., 1997). In addition,
the same dose of IL-1 may differentially affect sleep–wake behavior
depending upon the circadian time of its administration. For example,
10 ng of IL-1 administered ICV prior to the dark phase promotes
nonREM sleep, whereas this dose promotes wakefulness when given
prior to the light phase (Opp et al., 1991). The present study was
conducted during the light phase and a low concentration of IL-1 was
perfused to determine the acute response of the POA ⁄BF neurons. A
predominant suppression of wake-related neurons and activation of a
subset of sleep-related neurons by IL-1 as found in this study may be
the mechanism whereby nonREM sleep is promoted by IL-1. It is
possible that these neuronal populations would respond differently to
higher doses of IL-1.
The specific brain areas and pathways that mediate the nonREM
sleep-promoting effects of IL-1 remain poorly understood. However,
our study in conjunction with earlier studies suggests that IL-1
promotes nonREM sleep in part by acting on multiple arousal systems
and in part by inhibiting wake-related neurons. We recently demon-
strated that IL-1 may inhibit wake-promoting monoaminergic systems
in dorsal raphe and locus coeruleus (Manfridi et al., 2003). IL-1, when
Fig. 4. Effects of IL-1 on the mean discharge activity of POA ⁄ BF neurons.
Effects of IL-1 on the mean discharge rate (± SEM) of wake-related neurons
(A), sleep-related neurons (B) and state-indifferent neurons (C) during waking
and nonREM sleep. IL-1 suppressed the discharge rate of wake-related and
state-indifferent neurons. IL-1 produced no significant changes on the discharge
activity of sleep-related neurons as a group. **P < 0.01; *P < 0.05 (Wilcoxon
matched-pairs signed rank test).
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microinjected into the dorsal raphe of freely behaving rats, induces
nonREM sleep. In addition, we found in vitro that application of IL-1
suppresses the spontaneous discharge activity of physiologically and
pharmacologically identified serotonergic dorsal raphe neurons
(Manfridi et al., 2003). Finally, low doses of IL-1 microinjected into
locus coeruleus suppress neuronal activity, whereas higher doses
increase locus coeruleus neuronal activity, effects that are blocked by
IL-1ra (Borsody & Weiss, 2002). The strong suppression of discharge
rates of wake-related neurons in the present study is consistent with
the results of these previously published reports.
Sleep-related neurons have been identified in the ventrolateral POA
by c-Fos protein immunohistochemistry and unit recording studies
(Sherin et al., 1996; Szymusiak et al., 1998). Neurons in the
ventrolateral POA that express fos protein immunoreactivity during
sleep co-localize with galanin and GABA (Gaus et al., 2002; Gong
et al., 2004). In the present study, five of 13 sleep-related neurons were
recorded within and just dorsal to the ventrolateral POA and three of
these neurons were activated by IL-1. Although a limited number of
neurons were recorded in this region, these results suggest that sleep-
related neurons in the ventrolateral POA may in part mediate the
nonREM sleep-promoting effects of IL-1. This conclusion is consis-
tent with a recent study showing increased Fos-immunoreactivity in
ventrolateral POA neurons after bolus ICV administration of IL-1,
during which time these animals slept more than their respective
controls (Baker et al., 2003).
We found that IL-ra attenuates IL-1-induced suppression of the
discharge of wake-related neurons. These results suggest that IL-1-
induced suppression of wake-related neurons is receptor-mediated
and specific. These data complement and confirm earlier in vitro and
in vivo studies. For example, in vitro IL-ra blocks IL-1-induced
inhibition of thermosensitive neurons in the POA (Xin & Blatteis,
1992). In vivo, IL-1ra attenuates the hyperalgesia produced by
microinjection of IL-1 into the POA (Oka et al., 1995). ICV
administration of IL-1ra blocks IL-1-induced nonREM sleep and
fever (Opp & Krueger, 1991). Under the conditions of the present
study, IL-1ra significantly attenuates, but does not completely block,
IL-1-induced effects on POA ⁄BF neuronal activity of wake-related
neurons. In contrast to receptors for classical neurotransmitters, cells
Fig. 5. Effects of IL-1ra on the discharge activity of an individual wake-related neuron. Five-minute continuous recording showing the sleep- and wake-related
discharge activity of an individual wake-related neuron during baseline (A) and during IL-1ra perfusion (B). In response to IL-1ra, this neuron exhibited slightly
elevated discharge. The abbreviations and details as described in the legend to Fig. 2.
Fig. 6. Effects of IL-1ra on the mean discharge rate (± SEM) of POA ⁄ BF
neurons during waking and during nonREM sleep. IL-1ra did not affect the
mean discharge of neurons during waking or during nonREM sleep.
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taken from fresh tissue or circulating blood express few IL-1
receptors per cell (Dinarello, 1991; Rothwell & Luheshi, 2000).
Although transfected cells may contain up to 5000 receptors, primary
cells often contain 50–200 receptors (Shirakawa et al., 1989;
Dinarello, 1996). Not only are there few IL-1 receptors per cell,
but only about 5% of IL-1 receptors need to be occupied before
second messenger systems are activated (Gallis et al., 1989;
Stylianou et al., 1992). As such, essentially all IL-1 receptors must
be blocked by the IL-1ra before the biologic actions of IL-1 are
completely abolished. Because of these aspects of IL-1 biology, it is
often necessary to use many fold excess of IL-1ra to block IL-1
effects. For example, a 1000-fold excess of IL-1ra is required to
inhibit 50% of protein kinase activation in fibroblasts in vitro (Dripps
et al., 1991), and our previous studies indicate that 100 lg IL-1ra is
sufficient to block in vivo sleep and fever responses of rabbits to
10 ng IL-1, a 10 000-fold excess of IL-1ra to IL-1 (Opp & Krueger,
1991). Therefore, it is possible that in the present study the dose of
IL-1ra used (100 ng) was too small to block IL-1 effects on neuronal
discharge completely. Furthermore, the half-life of the IL-1ra in
cerebrospinal fluid is relatively short, about 10–15 min. The fact that
five wake-related neurons were responsive to IL-1 after perfusion of
the IL-1ra may also be due to the short half-life of the IL-1ra relative
to the duration of IL-1 perfusion that followed. Nevertheless, it is
clear that selectively and specifically antagonizing receptors before
perfusion of IL-1 alters the discharge rates of wake-related neurons in
a manner consistent with the hypothesis that promotion of nonREM
sleep by IL-1 may result from actions on these neurons.
Because central administration of IL-ra transiently reduces sponta-
neous nonREM sleep in rats (Opp & Krueger, 1991), one might
hypothesize that IL-ra itself should alter the spontaneous activity of
POA ⁄BF neurons. The aim of the present study was to demonstrate
specificity for IL-1 effects on neuronal activity. Therefore, most
neurons were examined for the effects of IL-1 in the presence of IL-ra
and fewer neurons were recorded during perfusion of IL-ra alone.
However, although a low dose of IL-1ra was used in this study, two of
four wake-related neurons exhibited increased discharge in the
presence of IL-ra. Although additional studies are required to elucidate
fully the impact of IL-1 on these neurons, these intriguing data suggest
that endogenous IL-1 may exert tonic inhibitory influences on wake-
related neurons.
The effects of IL-1 on various behaviorally identified POA ⁄BF
neurons, as described here, could be the result of direct postsynaptic
effects, presynaptic effects or a combination of both. Some evidence
suggests that the inhibitory effects of IL-1 on wake-related neurons
may be mediated by an adenosine-dependent mechanism. Both IL-1
protein and receptors and A1 receptors are expressed in several brain
regions, including the hypothalamus (Cunningham et al., 1992;
Schobitz et al., 1994; Yabuuchi et al., 1994; Ericsson et al., 1995;
Ribeiro, 1999; Muller, 2001). Adenosine has been implicated in the
homeostatic regulation of sleep (Porkka-Heiskanen et al., 2002) and
we have previously demonstrated that A1 receptor-mediated adenos-
inergic inhibition is involved in the suppression of BF neuronal
activity (Alam et al., 1999). In an in vitro hippocampal slice
preparation, IL-1 decreases glutamatergic excitatory postsynaptic
potentials, an effect blocked by an adenosine A1 receptor antagonist
(Luk et al., 1999). Endogenous glutamate plays an important role in
regulating the excitability of the BF arousal system; local BF
perfusion with glutamate antagonists prevents the increase in the
neocortical acetylcholine release evoked by brainstem stimulation
(Rasmusson et al., 1994). Although experiments to test this
hypothesis directly have not been conducted, suppression of
discharge in POA ⁄BF wake-related neurons evoked by IL-1 may
result, in part, from adenosinergic presynaptic modulation of
glutamate release. The hypothesis that adenosinergic mechanisms
are involved in mediating IL-1-induced inhibition of POA ⁄BF
neurons could be directly tested (1) by determining if IL-1 perfusion
into POA ⁄BF increases extracellular adenosine levels, and ⁄ or (2) by
determining if IL-1-induced effects on POA ⁄BF neuronal discharge
could be attenuated by application of an adenosine A1 receptor
antagonist.
Fig. 7. Effects of IL-1 in the presence of IL-ra on the discharge rate of an individual POA ⁄ BF neuron. Continuous tracings showing wake- and sleep-related dis-
charge activity of an individual wake-related neuron in POA ⁄ BF during baseline (A) and during IL-1ra + IL-1 perfusion (B). In the presence of IL-1ra, IL-1 failed to
suppress the discharge of this neuron. Abbreviations and other details are as in the legend to Fig. 2.
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Although responses of sleep-related neurons were more heteroge-
neous than those of wake-related neurons, five of 13 sleep-related
neurons exhibited increased discharge in response to IL-1. One
possible explanation for the heterogeneity of response stems from the
evidence that a variety of factors promote sleep within the POA ⁄BF
region (McGinty & Szymusiak, 2003; Obal & Krueger, 2003).
Considering the multiplicity of the regulatory outputs, it is possible
that subsets of sleep-related neurons have different thresholds for
various neurotransmitters or neuromodulators underlying the regula-
tion of different physiologic components within sleep. The activation
of a subset of sleep-related neurons is also consistent with the
hypothesis of a sleep-promoting role for IL-1. In vitro studies
demonstrate the ability of IL-1 to activate POA neurons (Nakashima
et al., 1989; Xin & Blatteis, 1992; Hori & Katafuchi, 1998), and to
increase intracellular Ca2+ in cultured hypothalamic GABAergic
neurons (De et al., 2002). Immunohistochemical studies from our
laboratory suggest that the majority of sleep-related neurons in the
POA subregion are GABAergic (Gong et al., 2004). Therefore, we
hypothesize that some of the sleep-related neurons directly activated by
IL-1 are GABAergic. It is also possible that the increased discharge of
sleep-related neurons is due to a reduction of inhibitory influences of
sleep-related neuronal synapses originating on wake-related neurons.
In summary, the data presented here demonstrate that IL-1
modulates the discharge activity of various POA ⁄BF neurons in a
manner that may induce spontaneous nonREM sleep. Our results also
demonstrate that the predominant effect of IL-1 is inhibition of wake-
related neuronal activity and that the modulatory effect of IL-1 on
POA ⁄BF neurons is mediated via IL-1 receptors.
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